EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Relationship between clinical features and blood levels of pentachlorodibenzofuran in patients with Yusho



Relationship between clinical features and blood levels of pentachlorodibenzofuran in patients with Yusho



Environmental Toxicology 22(2): 124-131



Background. Yusho is a form of food poisoning that occurred in 1968, as a result of consuming rice bran oil contaminated with polychlorinated biphenyls (PCBs) and various dioxins such as polychlorinated dibenzofurans (PCDFs). The victims of Yusho suffered from various dermatological, ophthalmological, and mucosal symptoms in addition to general fatigue, weight loss, anorexia, headache, paresthesia of the extremities, abdominal pain, cough and sputa, dysmenorrhea, and growth retardation in infants and children. We measured the blood levels of dioxins in the annual medical check-up of Yusho patients from 2001 to 2003. Purpose: To analyze the relationship between the concentrations of PCDFs/ PCBs and the subjective/objective/laboratory findings of patients with Yusho. We also compared the present clinical findings with those collected in 1988. Results and discussion: The mean blood level of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) in 359 patients with Yusho was 177.50 pg/g lipids, which was much higher than that of normal controls (15.2 +/- 8.9 pg/g lipids). The blood levels of PeCDF were significantly correlated with total PCB levels, hexachlorobiphenyl levels, urinary sugar, 2-h erythrocyte sedimentation rate, thymol turbidity test, and sodium levels. A significant correlation was also noted with dermatological findings (acneform eruption and comedones), mucosal findings (oral pigmentation), constipation, numbness in the extremities, body weight loss, and abnormal abdominal ultrasonography. The incidence and severity of most of the dermatological and ophthalmological symptoms decreased from 1988 to 2001-2003. In conclusion, high amounts of PCBs and PeCDF are still present in a number of patients with Yusho. The patients still suffer from various mucocutaneous and subjective symptoms. (c) 2007 Wiley Pedodicals, Inc.

(PDF emailed within 0-6 h: $19.90)

Accession: 013265169

Download citation: RISBibTeXText

PMID: 17366567

DOI: 10.1002/tox.20251



Related references

Unexpectedly long half-lives of blood 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) levels in Yusho patients. Environmental Health 14(): 76-76, 2016

Differential correlation of medical/laboratory examinations with blood levels of polychlorinated biphenyls, polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran in Yusho patients from 2001 to 2004. Fukuoka Igaku Zasshi 100(5): 166-171, 2009

Relationship of clinical symptoms and laboratory findings with blood levels of PCDFs in patients with Yusho. Journal of Dermatological Science (Suppl. 1): S85-S93, 2005

Relationship of clinical symptoms and laboratory findings with blood levels of PCDFs in patients with Yusho. Journal of Dermatological Science Supplement 1(1), 2005

Relationship between blood dioxin levels and present/past clinical symptoms in Kanemi Yusho patients. Fukuoka Igaku Zasshi 98(5): 153-159, 2007

The past history of diseases and symptoms among the Yusho patients, and its association with blood lipid concentration of 2,3,4,7,8-pentachlorodibenzofuran. Fukuoka Igaku Zasshi 98(5): 160-165, 2007

Association of clinical findings in Yusho patients with serum concentrations of polychlorinated biphenyls, polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran more than 30 years after the poisoning event. Environmental Health 7(): 47-47, 2008

Average of the PCDFs value in blood in patients with Yusho in the 2001 to 2003 fiscal year and comparison between the clinical features and PCDFs. Fukuoka Igaku Zasshi 98(5): 129-135, 2007

Blood levels of PCDDs, PCDFs, and coplanar PCBs in Yusho mothers and their descendants: association with fetal Yusho disease. Chemosphere 90(5): 1581-1588, 2013

Levels of pcdds coplanar pcbs and pcdfs in patients with yusho disease and in the yusho oil. Chemosphere 18(1-6): 407-416, 1989

PCB, PCQ and PCT in the rice oil which caused "yusho" and in the blood of patients with yusho. Fukuoka Igaku Zasshi 76(5): 126-131, 1985

Relationship between blood PCDFs level and symptoms in Yusho patients. Fukuoka Igaku Zasshi 96(5): 169-179, 2005

Analysis of residual nature of dioxins in blood of Yusho patients and controls in relation to the Yusho oil and food as respective exposure routes. Fukuoka Igaku Zasshi 98(5): 196-202, 2007

Levels of PCDDs, PCDFs and coplanar PCBs in sebum and blood of Yusho patients. Fukuoka Igaku Zasshi 88(5): 177-185, 1997

Exposed and control human blood levels from Guam and Binghamton workers and Yusho patients. Chemosphere 25(7-10): 1091-1094, 1992